Godeshala Sudhakar

Lipid Nanocarriers of a Lipid-Conjugated Estrogenic Derivative Inhibit Tumor Growth and Enhance Cisplatin Activity against Triple-Negative Breast Cancer: Pharmacokinetic and Efficacy Evaluation

Terrick Andey, Godeshala Sudhakar, Srujan Marepally et al. · Molecular Pharmaceutics · 2015 · 75 citations

Breast Oncology, Tumor Biology, Nanomedicine +17

A Lipid-Modified Estrogen Derivative that Treats Breast Cancer Independent of Estrogen Receptor Expression through Simultaneous Induction of Autophagy and Apoptosis

Sutapa Sinha, Sayantani Roy, Bathula Surendar Reddy et al. · Molecular Cancer Research · 2011 · 45 citations · Full text

Cell Autophagy, Breast Oncology, Simultaneous Induction +14

Asymmetric cationic lipid based non-viral vectors for an efficient nucleic acid delivery

Rakeshchandra R. Meka, Godeshala Sudhakar, Srujan Marepally et al. · RSC Advances · 2016 · 26 citations

Lipid Preparation, Proteinlipid Interaction, Engineering +14

Development of new estradiol-cationic lipid hybrids: Ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity

Godeshala Sudhakar, Surendar Reddy Bathula · European Journal of Medicinal Chemistry · 2014 · 22 citations

Lipid Preparation, Lipid Synthesis, Medicine +7

17β-Estradiol-Linked Nitro-<scp>l</scp>-arginine as Simultaneous Inducer of Apoptosis in Melanoma and Tumor-Angiogenic Vascular Endothelial Cells

Sayantani Roy, Bathula Surendar Reddy, Godeshala Sudhakar et al. · Molecular Pharmaceutics · 2011 · 17 citations

Chemoprevention Strategy, Apoptosis, Cell Death +19